Skip to content

A study in healthy people to compare how 2 different formulations of vicadrostat / empagliflozin tablets are taken up in the body

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-524773-16-00
Enrollment
36
Registered
2026-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Interventions

None listed

Sponsors

Boehringer Ingelheim International GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Aug 7, 2026